Mana Capital Acquisition Corp. Completes Business Combination with Cardio Diagnostics (Cardio Diagnostics Holdings, Inc.)

CardioOne Acquires CardioDiagnostics

April 24, 2025

Healthcare Services

CardioOne, a national growth and operational partner for independent cardiology practices, has acquired CardioDiagnostics, a provider of advanced ECG and remote patient monitoring (RPM) technologies. The deal integrates CardioDiagnostics’ cloud-based monitoring, analytics and RPM capabilities into CardioOne’s practice management platform to expand virtual care and enhance cardiology practice services.

HH&L Acquisition Co. Merges With DiaCarta to Create a Public Company

October 14, 2022

Healthcare Services

DiaCarta entered into a definitive business combination agreement with SPAC HH&L Acquisition Co. to become a publicly listed company. The transaction is expected to provide DiaCarta access to approximately $414 million held in HH&L’s IPO trust and is expected to close in the first quarter of 2023.

Wellspring Capital Management Acquires Center for Diagnostic Imaging

March 15, 2019

Healthcare Services

Wellspring Capital Management, a New York-based private equity firm, has closed the acquisition of Center for Diagnostic Imaging (CDI), a Minneapolis-headquartered provider of outpatient diagnostic imaging and interventional radiology services. Wellspring said it will partner with CDI's management to support growth initiatives, operating improvements and potential add-on acquisitions to expand CDI's national network and capabilities.

Novo Nordisk to Acquire Cardior Pharmaceuticals for Up to €1.025 Billion

March 25, 2024

Biotechnology

Novo Nordisk agreed to acquire Cardior Pharmaceuticals for up to €1.025 billion, consisting of an upfront payment plus additional milestone payments tied to development and commercial progress. The deal is expected to strengthen Novo Nordisk’s cardiovascular pipeline, centered on Cardior’s lead candidate CDR132L in phase 2 heart failure trials.

Haemonetics Acquires Cardiva Medical

January 20, 2021

Medical Devices

Haemonetics Corporation agreed to acquire Cardiva Medical, Inc., a privately-held maker of vascular closure systems based in Santa Clara, California, for $475 million upfront and up to $35 million in contingent consideration. The acquisition expands Haemonetics' hospital portfolio and its presence in the interventional cardiology and electrophysiology markets and is expected to be accretive to revenue growth.

Martis Capital Invests in DCN Dx

November 19, 2020

Medical Devices

Martis Capital has made a growth equity investment in DCN Dx, a Carlsbad, California-based lateral flow diagnostics developer and contract developer of rapid point-of-care tests. As part of the transaction, Charlie Mamrak will join DCN Dx as CEO; the capital will be used to accelerate growth and expand the company's diagnostic capabilities. Financial terms were not disclosed and Pegasus Capital and TM Capital advised on the deal.